These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4325773)

  • 41. [Alpha interferon, antiviral proteins and their value in clinical medicine].
    Chieux V; Hober D; Chehadeh W; Wattré P
    Ann Biol Clin (Paris); 1999; 57(6):659-66. PubMed ID: 10572214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Some factors affecting interferon production by foot-and-mouth disease virus in bovine tissue cultues.
    Sellers RF; Bennett JH; Mowat GN; Snowdon WA
    Arch Gesamte Virusforsch; 1968; 23(1):1-11. PubMed ID: 4300584
    [No Abstract]   [Full Text] [Related]  

  • 43. Inhibition of interferon production by chloroquine diphosphate.
    Kono S; Kohase M; Suganuma M
    Jpn J Med Sci Biol; 1968 Aug; 21(4):239-48. PubMed ID: 4303419
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of heparin on reproduction of, and interferon production and interference by, Newcastle disease virus in chick embryo cell cultures.
    Mentkevich LM; Zhdanova LV
    Acta Virol; 1971 May; 15(3):233-6. PubMed ID: 4397344
    [No Abstract]   [Full Text] [Related]  

  • 45. The use of interferon production as a marker in the development of a modified strain of foot-and-mouth disease virus.
    Sellers RF; Mowat GN; Bennett JH; Barr DA
    Arch Gesamte Virusforsch; 1968; 23(1):12-9. PubMed ID: 4300581
    [No Abstract]   [Full Text] [Related]  

  • 46. Properties in cell cultures of a hamster brain-adapted subacute sclerosing panencephalitis virus.
    Castro AE; Burnstein T; Byington DP
    J Gen Virol; 1972 Sep; 16(3):413-7. PubMed ID: 4342825
    [No Abstract]   [Full Text] [Related]  

  • 47. [The toxic effect of vesicular stomatitis virus on mouse peritoneal exudate phagocytes].
    Solilova LV; Il'in GI; Kiazimova AA; Smorodintsev AA
    Vopr Virusol; 1970; 15(6):670-4. PubMed ID: 4325901
    [No Abstract]   [Full Text] [Related]  

  • 48. Heterologous activity of monkey interferons.
    Uhlendorf CP; Zimmerman EM; Baron S
    Proc Soc Exp Biol Med; 1973 Nov; 144(2):628-32. PubMed ID: 4355757
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.
    Werner GH; Jasmin C; Chermann JC
    J Gen Virol; 1976 Apr; 31(1):59-64. PubMed ID: 177729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of tissue viral resistance in chickens following administration of interferon inducers.
    Finkelstein MS
    J Immunol; 1972 Jun; 108(6):1506-16. PubMed ID: 4337965
    [No Abstract]   [Full Text] [Related]  

  • 51. [Interferon production stimulation in the white mouse by dimethylsulfoxide (DMSO)].
    Kunze M; Hofmann H; Klein HJ
    Zentralbl Bakteriol Orig; 1971; 216(4):527-31. PubMed ID: 4326011
    [No Abstract]   [Full Text] [Related]  

  • 52. A simple interferon assay as an adjunct for determining the genus of origin of cell cultures.
    Zimmerman EM; Freeman AE; Price PJ; Holbrook Z; Uhlendorf CP
    In Vitro; 1972; 8(2):85-90. PubMed ID: 4346259
    [No Abstract]   [Full Text] [Related]  

  • 53. Increase in antiviral activity of polynucleotides by thermal activation.
    De Clercq E; Wells RD; Merigan TC
    Nature; 1970 Apr; 226(5243):364-6. PubMed ID: 4314782
    [No Abstract]   [Full Text] [Related]  

  • 54. Interferon: enhanced synthesis and action in mouse and human cells under suboptimal growth conditions.
    Carter WA
    Johns Hopkins Med J; 1972 Mar; 130(3):166-73. PubMed ID: 4110584
    [No Abstract]   [Full Text] [Related]  

  • 55. Interferon induced by polyinosinic-polycytidylic acid in interferon pretreated L cells in absence of DEAE-dextran.
    Rosztóczy I
    Acta Virol; 1971 Sep; 15(5):431. PubMed ID: 4399145
    [No Abstract]   [Full Text] [Related]  

  • 56. Attempted induction of interferon by bacterial vaccines in allergic and nonallergic humans.
    Johnstone DE; Douglas RG; Simon R
    Ann Allergy; 1974 Feb; 32(2):70-2. PubMed ID: 4149323
    [No Abstract]   [Full Text] [Related]  

  • 57. Efficacy of exogenous interferon treatment initiated after onset of multiplication of vesicular stomatitis virus in the brains of mice.
    Gresser I; Tovey MG; Bourali-Maury C
    J Gen Virol; 1975 Jun; 27(3):395-8. PubMed ID: 167120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An antiviral soluble form of the LDL receptor induced by interferon.
    Fischer DG; Tal N; Novick D; Barak S; Rubinstein M
    Science; 1993 Oct; 262(5131):250-3. PubMed ID: 8211145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclic production of vesicular stomatitis virus caused by defective interfering particles.
    Palma EL; Huang A
    J Infect Dis; 1974 Apr; 129(4):402-10. PubMed ID: 4361583
    [No Abstract]   [Full Text] [Related]  

  • 60. Differing responses of hamsters to infection by vesicular stomatitis virus Indiana and New Jersey serotypes.
    Fultz PN; Holland JJ
    Virus Res; 1985 Sep; 3(2):129-40. PubMed ID: 2414943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.